eMERGE is a national network organized and funded by the
National Human Genome Research Institute (NHGRI) that combines DNA
biorepositories with electronic medical record (EMR) systems for large
scale, high-throughput genetic research in support of implementing genomic
medicine.

Many factors contribute to risk of a disease. Some of these factors are internal,
like genetics, and others are external, like where someone lives. Over the last several years
researchers have discovered that in addition to one gene being associated with a given
disease (monogenic factors), many genes across your genome can contribute to the development
of a disease (polygenic factors). To learn more about elements that contribute to risk a disease,
click here.
Latest News
DEADLINE EXTENDED, Now April 14th: NCI/AcademyHealth Visiting Scholars Program
March 3, 2025 9:41 PM
Inviting Feedback on the Framework for the NIH Strategic Plan for Disability Health Research FY26-FY30
January 1, 2025 7:38 PM
CTSA Collaborative & Innovative Acceleration (CCIA) Award NOFO and Notice for TA webinar
January 1, 2025 7:37 PM
NHGRI 2025 Training Meeting
December 12, 2024 10:27 PM
Funding Announcement: RFA-HG-25-005
November 11, 2024 2:36 PM
FY25 Bioethics NOSI is Live
October 10, 2024 7:32 PM
Recent Publications
Kim J, Williams A, Noh H, Jasper EA, Hellwege JN, et al. Genome-wide meta-analysis identifies novel risk loci for uterine fibroids within and across multiple ancestry groups. Nature communications. 2025 Mar 6;16(1):2273.
Papadopoulou A, Litkowski EM, Graff M, Wang Z, Marouli E, et al. Insights from the largest diverse ancestry sex-specific disease map for genetically predicted height. NPJ genomic medicine. 2025 Feb 27;10(1):14.
Naderian M, Kullo IJ. Genetic risk disclosure and behavioural change: not so fast. European journal of preventive cardiology. 2025 Feb 5;.